These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3635127)
1. Pharmacologic approach to ischemic stroke management. Kasuya A; Holm K Nurs Clin North Am; 1986 Jun; 21(2):289-96. PubMed ID: 3635127 [TBL] [Abstract][Full Text] [Related]
2. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. Genton E Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166 [No Abstract] [Full Text] [Related]
3. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts). Genton E; Gent M; Hirsh J; Harker LA N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977 [No Abstract] [Full Text] [Related]
4. Does aspirin prevent stroke? Mitchell JR Practitioner; 1979 Nov; 223(1337):668-72. PubMed ID: 394138 [No Abstract] [Full Text] [Related]
5. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
10. Stroke therapy: status of anti-platelet aggregation drugs. Yatsu FM Neurology; 1977 Jun; 27(6):503-4. PubMed ID: 325429 [No Abstract] [Full Text] [Related]
11. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144 [TBL] [Abstract][Full Text] [Related]
12. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke]. Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029 [No Abstract] [Full Text] [Related]
13. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
14. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease. Passamani ER Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348 [TBL] [Abstract][Full Text] [Related]
15. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis. Büttner T; Hellwig K; Müller T; Kuhn W Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285 [TBL] [Abstract][Full Text] [Related]
16. [Anti-platelet therapy in ischemic cerebrovascular disorder--clinical and hematological study]. Yoshii K; Seki Y; Aiba T; Tsukada T; Shiozawa R No To Shinkei; 1985 Oct; 37(10):985-90. PubMed ID: 4074576 [TBL] [Abstract][Full Text] [Related]
17. Using antithrombotic therapy in ischemic cerebrovascular disease. Gotshall RA; Harker LA Geriatrics; 1977 Nov; 32(11):101-4. PubMed ID: 924145 [No Abstract] [Full Text] [Related]
19. For your stroke-prone patients: a guide to drug treatment. Yatsu FM Geriatrics; 1980 Feb; 35(2):34-47. PubMed ID: 7356588 [No Abstract] [Full Text] [Related]